- Home
- AMWL vs ADCT Comparison
AMWL vs ADCT Comparison
Compare AMWL & ADCT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- AMWL
- ADCT
- Stock Information
- Founded
- AMWL 2006
- ADCT 2011
- Country
- AMWL United States
- ADCT Switzerland
- Employees
- AMWL N/A
- ADCT N/A
- Industry
- AMWL Retail: Computer Software & Peripheral Equipment
- ADCT Biotechnology: Pharmaceutical Preparations
- Sector
- AMWL Technology
- ADCT Health Care
- Exchange
- AMWL Nasdaq
- ADCT Nasdaq
- Market Cap
- AMWL 165.1M
- ADCT 143.1M
- IPO Year
- AMWL 2020
- ADCT 2020
- Fundamental
- Price
- AMWL $11.74
- ADCT $1.63
- Analyst Decision
- AMWL Hold
- ADCT Strong Buy
- Analyst Count
- AMWL 6
- ADCT 5
- Target Price
- AMWL $11.90
- ADCT $8.00
- AVG Volume (30 Days)
- AMWL 90.5K
- ADCT 480.5K
- Earning Date
- AMWL 02-12-2025
- ADCT 03-12-2025
- Dividend Yield
- AMWL N/A
- ADCT N/A
- EPS Growth
- AMWL N/A
- ADCT N/A
- EPS
- AMWL N/A
- ADCT N/A
- Revenue
- AMWL $254,364,000.00
- ADCT $70,717,000.00
- Revenue This Year
- AMWL $25.21
- ADCT $6.81
- Revenue Next Year
- AMWL $7.96
- ADCT $11.23
- P/E Ratio
- AMWL N/A
- ADCT N/A
- Revenue Growth
- AMWL N/A
- ADCT N/A
- 52 Week Low
- AMWL $5.00
- ADCT $1.39
- 52 Week High
- AMWL $22.60
- ADCT $5.38
- Technical
- Relative Strength Index (RSI)
- AMWL 57.59
- ADCT 46.49
- Support Level
- AMWL $11.18
- ADCT $1.55
- Resistance Level
- AMWL $12.95
- ADCT $1.73
- Average True Range (ATR)
- AMWL 0.81
- ADCT 0.12
- MACD
- AMWL -0.04
- ADCT 0.03
- Stochastic Oscillator
- AMWL 57.90
- ADCT 63.16
About AMWL American Well Corporation
American Well Corp is a telehealth company enabling digital delivery of care for its customers. Its platform, Amwell, digital care delivery solution that equips health systems, health plans, government, and innovator clients with the tools to enable new models of care for their patients and members enabling care delivery across the full healthcare continuum - from primary and urgent care in the home to high acuity specialty consults, such as telestroke and telepsychiatry, in the hospital. It provides both on-demand and scheduled consultations. Its Health Plan Programs include Virtual Primary Care, Musculoskeletal Care, Dermatology Care, and Chronic Care among others.
About ADCT ADC Therapeutics SA
ADC Therapeutics SA is a commercial-stage oncology-focused biotechnology company. It is involved in the development of antibody-drug conjugates for patients suffering from hematological malignancies and solid tumors. The company's product candidate includes ZYNLONTA, camidanlumab tesirine, ADCT-602, ADCT-601, ADCT-901, ADCT-701 and ADCT-212.